MedPath

EPINEPHRINE

EPINEPHRINE INJ. USP, 0.1 mg/mL 1mg per 10mL LUER-JET™ SYR

Approved
Approval ID

e651aebd-f619-c3a6-e053-2995a90aea01

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 15, 2022

Manufacturers
FDA

HF Acquisition Co LLC, DBA HealthFirst

DUNS: 045657305

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

EPINEPHRINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51662-1381
Product Classification
G
Generic Name
EPINEPHRINE
Product Specifications
Route of AdministrationINTRACARDIAC, INTRAVENOUS
Effective DateAugust 15, 2022
FDA Product Classification

INGREDIENTS (6)

SODIUM BISULFITEInactive
Code: TZX5469Z6I
Classification: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
EPINEPHRINEActive
Quantity: 0.1 mg in 1 mL
Code: YKH834O4BH
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.